Answers are grounded in this paper and cite their sources.
Study assessed the antioxidant and antimicrobial properties of metal complexes in vitro, highlighting their potential applications.
The new azo dye ligand 1-(2,4,6-trihydroxy-3-(2-hydroxy-phenylazo)phenyl)ethanone (H2L) was produced by reacting the diazonium salt derived from 2-aminophenol, with 2,4,6-trihydroxyacetophenone. This ligand was used to create several azo dye-metal complexes through reactions with salts of V(IV), Fe(III), Cr(III), Mn(II), Mo(VI), and Ru(III). The ligand was characterized using 1H- and 13C-NMR spectroscopy. The metal complexes were analyzed via UV-vis, FTIR, MS, thermal analysis (TGA, DSC), conductivity measurements, magnetic susceptibility, metal/chlorine content, and melting point determination. The results showed that the ligand acts as a tetradentate ligand with Ru, Mo, and VO, and as a tridentate ligand with Cr, Mn, and Fe. All complexes were octahedral in shape, except for the vanadium complex, which exhibited a square pyramidal structure. All complexes exhibited non-electrolytic properties. The compounds' capacity to act as antioxidants was assessed by measuring their ability to inhibit the DPPH free radical, with ascorbic acid serving as a standard reference. The half-maximal inhibitory concentration (IC50) values were determined, revealing the following order of activity: H2L > Ru-complex > Fe-complex > ascorbic acid = VO-complex = Mo-complex > Mn-complex > Cr-complex. The compounds were also tested for antibacterial and antifungal activity at two concentrations.
No takes yet. Share an insight, caveat, or question.
Al-Agele et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: